239 related articles for article (PubMed ID: 18536581)
1. Modern treatment of Hodgkin lymphoma.
Bartlett NL
Curr Opin Hematol; 2008 Jul; 15(4):408-14. PubMed ID: 18536581
[TBL] [Abstract][Full Text] [Related]
2. Early 18F-labeled fluoro-2-deoxy-D-glucose positron emission tomography scanning in the lymphomas: changing the paradigms of treatments?
Coleman M; Kostakoglu L
Cancer; 2006 Oct; 107(7):1425-8. PubMed ID: 16933331
[TBL] [Abstract][Full Text] [Related]
3. Controversies on the prognostic value of interim FDG-PET in advanced-stage Hodgkin lymphoma.
Adams HJ; Kwee TC
Eur J Haematol; 2016 Dec; 97(6):491-498. PubMed ID: 27528557
[TBL] [Abstract][Full Text] [Related]
4. Combined modality treatment of Hodgkin's lymphoma.
Klimm B; Engert A
Cancer J; 2009; 15(2):143-9. PubMed ID: 19390310
[TBL] [Abstract][Full Text] [Related]
5. The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scale.
Gallamini A; Barrington SF; Biggi A; Chauvie S; Kostakoglu L; Gregianin M; Meignan M; Mikhaeel GN; Loft A; Zaucha JM; Seymour JF; Hofman MS; Rigacci L; Pulsoni A; Coleman M; Dann EJ; Trentin L; Casasnovas O; Rusconi C; Brice P; Bolis S; Viviani S; Salvi F; Luminari S; Hutchings M
Haematologica; 2014 Jun; 99(6):1107-13. PubMed ID: 24658820
[TBL] [Abstract][Full Text] [Related]
6. Treatment of early-stage nonbulky Hodgkin lymphoma.
Straus DJ
Curr Opin Oncol; 2006 Sep; 18(5):432-6. PubMed ID: 16894289
[TBL] [Abstract][Full Text] [Related]
7. Early versus late intensification for patients with high-risk Hodgkin lymphoma-3 cycles of intensive chemotherapy plus low-dose lymph node radiation therapy versus 4 cycles of combined doxorubicin, bleomycin, vinblastine, and dacarbazine plus myeloablative chemotherapy with autologous stem cell transplantation: five-year results of a randomized trial on behalf of the GOELAMS Group.
Arakelyan N; Berthou C; Desablens B; de Guibert S; Delwail V; Moles MP; Quittet P; Jais JP; Colonna P; Andrieu JM;
Cancer; 2008 Dec; 113(12):3323-30. PubMed ID: 18988286
[TBL] [Abstract][Full Text] [Related]
8. Involved-nodal radiation therapy as a component of combination therapy for limited-stage Hodgkin's lymphoma: a question of field size.
Campbell BA; Voss N; Pickles T; Morris J; Gascoyne RD; Savage KJ; Connors JM
J Clin Oncol; 2008 Nov; 26(32):5170-4. PubMed ID: 18838714
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease.
Subbiah V
N Engl J Med; 2008 Feb; 358(7):743; author reply 743. PubMed ID: 18283721
[No Abstract] [Full Text] [Related]
10. Hodgkin lymphoma in Tyrol-a population-based study.
Fong D; Steurer M; Greil R; Gunsilius E; Spizzo G; Gastl G; Tzankov A
Ann Hematol; 2009 May; 88(5):449-56. PubMed ID: 18846373
[TBL] [Abstract][Full Text] [Related]
11. Use of 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography in the early diagnosis of asymptomatic bleomycin-induced pneumonitis.
Connerotte T; Lonneux M; de Meeƻs Y; Hermans C; Vekemans MC; Ferrant A; Van Den Neste E
Ann Hematol; 2008 Nov; 87(11):943-5. PubMed ID: 18443792
[No Abstract] [Full Text] [Related]
12. Pediatric hodgkin lymphoma: maximizing efficacy and minimizing toxicity.
Hodgson DC; Hudson MM; Constine LS
Semin Radiat Oncol; 2007 Jul; 17(3):230-42. PubMed ID: 17591570
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic accuracy of serial CT/magnetic resonance imaging review vs. positron emission tomography/CT in colorectal cancer patients with suspected and known recurrence.
Potter KC; Husband JE; Houghton SL; Thomas K; Brown G
Dis Colon Rectum; 2009 Feb; 52(2):253-9. PubMed ID: 19279420
[TBL] [Abstract][Full Text] [Related]
14. The role of FDG-PET imaging and involved field radiotherapy in relapsed or refractory diffuse large B-cell lymphoma.
Hoppe BS; Moskowitz CH; Zhang Z; Maragulia JC; Rice RD; Reiner AS; Hamlin PA; Zelenetz AD; Yahalom J
Bone Marrow Transplant; 2009 Jun; 43(12):941-8. PubMed ID: 19139730
[TBL] [Abstract][Full Text] [Related]
15. Hodgkin Lymphoma: Diagnosis and Treatment.
Ansell SM
Mayo Clin Proc; 2015 Nov; 90(11):1574-83. PubMed ID: 26541251
[TBL] [Abstract][Full Text] [Related]
16. Thymic 18F-fluorodeoxyglucose uptake on positron emission tomography scanning after doxorubicin, bleomycin, vincristin and dacarbazine chemotherapy and highly-active antiretroviral therapy in HIV-associated Hodgkin's disease in an adult.
Lee SM; Buchler T; Bomanji J; Ramsay A; Edwards SG
AIDS; 2008 Jan; 22(1):159-60. PubMed ID: 18090408
[No Abstract] [Full Text] [Related]
17. ACR Appropriateness Criteria on Hodgkin's lymphoma: favorable prognosis stage I and II.
Das P; Ng A; Constine LS; Hodgson DC; Mendenhall NP; Morris DE; Yunes MJ; Chauvenet AR; Hudson MM; Winter JN
J Am Coll Radiol; 2008 Oct; 5(10):1054-66. PubMed ID: 18812149
[TBL] [Abstract][Full Text] [Related]
18. Do we need an early unfavorable (intermediate) stage of Hodgkin's lymphoma?
Specht L; Raemaekers J
Hematol Oncol Clin North Am; 2007 Oct; 21(5):881-96. PubMed ID: 17908626
[TBL] [Abstract][Full Text] [Related]
19. SOHO State of the Art Updates and Next Questions: Hodgkin Lymphoma.
Watkins MP; Fanale MA; Bartlett NL
Clin Lymphoma Myeloma Leuk; 2018 Feb; 18(2):81-90. PubMed ID: 29366607
[TBL] [Abstract][Full Text] [Related]
20. Personalized treatment of lymphoma: promise and reality.
Ramsdale E; van Besien K; Smith SM
Semin Oncol; 2011 Apr; 38(2):225-35. PubMed ID: 21421112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]